239 related articles for article (PubMed ID: 30067310)
1. Mutant NR5A1/SF-1 in patients with disorders of sex development shows defective activation of the SOX9 TESCO enhancer.
Sreenivasan R; Ludbrook L; Fisher B; Declosmenil F; Knower KC; Croft B; Bird AD; Ryan J; Bashamboo A; Sinclair AH; Koopman P; McElreavey K; Poulat F; Harley VR
Hum Mutat; 2018 Dec; 39(12):1861-1874. PubMed ID: 30067310
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the gene coding for steroidogenic factor 1 (SF1, NR5A1) in a cohort of 50 Egyptian patients with 46,XY disorders of sex development.
Tantawy S; Mazen I; Soliman H; Anwar G; Atef A; El-Gammal M; El-Kotoury A; Mekkawy M; Torky A; Rudolf A; Schrumpf P; Grüters A; Krude H; Dumargne MC; Astudillo R; Bashamboo A; Biebermann H; Köhler B
Eur J Endocrinol; 2014 May; 170(5):759-67. PubMed ID: 24591553
[TBL] [Abstract][Full Text] [Related]
3. Failure of SOX9 regulation in 46XY disorders of sex development with SRY, SOX9 and SF1 mutations.
Knower KC; Kelly S; Ludbrook LM; Bagheri-Fam S; Sim H; Bernard P; Sekido R; Lovell-Badge R; Harley VR
PLoS One; 2011 Mar; 6(3):e17751. PubMed ID: 21412441
[TBL] [Abstract][Full Text] [Related]
4. Mutation analysis of NR5A1 encoding steroidogenic factor 1 in 77 patients with 46, XY disorders of sex development (DSD) including hypospadias.
Allali S; Muller JB; Brauner R; Lourenço D; Boudjenah R; Karageorgou V; Trivin C; Lottmann H; Lortat-Jacob S; Nihoul-Fékété C; De Dreuzy O; McElreavey K; Bashamboo A
PLoS One; 2011; 6(10):e24117. PubMed ID: 22028768
[TBL] [Abstract][Full Text] [Related]
5. Novel NR5A1 Pathogenic Variants Cause Phenotypic Heterogeneity in 46,XY Disorders of Sex Development.
Sudhakar DVS; Jaishankar S; Regur P; Kumar U; Singh R; Kabilan U; Namduri S; Dhyani J; Gupta NJ; Chakravarthy B; Vaman K; Shabir I; Khadgawat R; Deenadayal M; Chaitanya A D; Dada R; Sharma Y; Anand A; Thangaraj K
Sex Dev; 2019; 13(4):178-186. PubMed ID: 32008008
[TBL] [Abstract][Full Text] [Related]
6. Mutational and functional studies on NR5A1 gene in 46,XY disorders of sex development: identification of six novel loss of function mutations.
Rocca MS; Ortolano R; Menabò S; Baronio F; Cassio A; Russo G; Balsamo A; Ferlin A; Baldazzi L
Fertil Steril; 2018 Jun; 109(6):1105-1113. PubMed ID: 29935645
[TBL] [Abstract][Full Text] [Related]
7. Excess DAX1 leads to XY ovotesticular disorder of sex development (DSD) in mice by inhibiting steroidogenic factor-1 (SF1) activation of the testis enhancer of SRY-box-9 (Sox9).
Ludbrook LM; Bernard P; Bagheri-Fam S; Ryan J; Sekido R; Wilhelm D; Lovell-Badge R; Harley VR
Endocrinology; 2012 Apr; 153(4):1948-58. PubMed ID: 22294746
[TBL] [Abstract][Full Text] [Related]
8. Screening and familial characterization of copy-number variations in NR5A1 in 46,XY disorders of sex development and premature ovarian failure.
Harrison SM; Campbell IM; Keays M; Granberg CF; Villanueva C; Tannin G; Zinn AR; Castrillon DH; Shaw CA; Stankiewicz P; Baker LA
Am J Med Genet A; 2013 Oct; 161A(10):2487-94. PubMed ID: 23918653
[TBL] [Abstract][Full Text] [Related]
9. The novel p.Cys65Tyr mutation in NR5A1 gene in three 46,XY siblings with normal testosterone levels and their mother with primary ovarian insufficiency.
Fabbri HC; de Andrade JG; Soardi FC; de Calais FL; Petroli RJ; Maciel-Guerra AT; Guerra-Júnior G; de Mello MP
BMC Med Genet; 2014 Jan; 15():7. PubMed ID: 24405868
[TBL] [Abstract][Full Text] [Related]
10. Mutations in the testis-specific enhancer of SOX9 in the SRY independent sex-determining mechanism in the genus Tokudaia.
Kimura R; Murata C; Kuroki Y; Kuroiwa A
PLoS One; 2014; 9(9):e108779. PubMed ID: 25265165
[TBL] [Abstract][Full Text] [Related]
11. Wide spectrum of NR5A1-related phenotypes in 46,XY and 46,XX individuals.
Domenice S; Machado AZ; Ferreira FM; Ferraz-de-Souza B; Lerario AM; Lin L; Nishi MY; Gomes NL; da Silva TE; Silva RB; Correa RV; Montenegro LR; Narciso A; Costa EM; Achermann JC; Mendonca BB
Birth Defects Res C Embryo Today; 2016 Dec; 108(4):309-320. PubMed ID: 28033660
[TBL] [Abstract][Full Text] [Related]
12. Testosterone production during puberty in two 46,XY patients with disorders of sex development and novel NR5A1 (SF-1) mutations.
Tantawy S; Lin L; Akkurt I; Borck G; Klingmüller D; Hauffa BP; Krude H; Biebermann H; Achermann JC; Köhler B
Eur J Endocrinol; 2012 Jul; 167(1):125-30. PubMed ID: 22474171
[TBL] [Abstract][Full Text] [Related]
13. A novel heterozygous mutation of steroidogenic factor-1 (SF-1/Ad4BP) gene (NR5A1) in a 46, XY disorders of sex development (DSD) patient without adrenal failure.
Tajima T; Fujiwara F; Fujieda K
Endocr J; 2009; 56(4):619-24. PubMed ID: 19318730
[TBL] [Abstract][Full Text] [Related]
14. The spectrum of phenotypes associated with mutations in steroidogenic factor 1 (SF-1, NR5A1, Ad4BP) includes severe penoscrotal hypospadias in 46,XY males without adrenal insufficiency.
Köhler B; Lin L; Mazen I; Cetindag C; Biebermann H; Akkurt I; Rossi R; Hiort O; Grüters A; Achermann JC
Eur J Endocrinol; 2009 Aug; 161(2):237-42. PubMed ID: 19439508
[TBL] [Abstract][Full Text] [Related]
15. Mutation update for the NR5A1 gene involved in DSD and infertility.
Fabbri-Scallet H; de Sousa LM; Maciel-Guerra AT; Guerra-Júnior G; de Mello MP
Hum Mutat; 2020 Jan; 41(1):58-68. PubMed ID: 31513305
[TBL] [Abstract][Full Text] [Related]
16. Two novel mutations in the NR5A1 gene as a cause of disorders of sex development in a Pakistani cohort of 46,XY patients.
Hussain S; Amar A; Najeeb MN; Khaliq S
Andrologia; 2016 Jun; 48(5):509-17. PubMed ID: 26260161
[TBL] [Abstract][Full Text] [Related]
17. Human sex reversal is caused by duplication or deletion of core enhancers upstream of SOX9.
Croft B; Ohnesorg T; Hewitt J; Bowles J; Quinn A; Tan J; Corbin V; Pelosi E; van den Bergen J; Sreenivasan R; Knarston I; Robevska G; Vu DC; Hutson J; Harley V; Ayers K; Koopman P; Sinclair A
Nat Commun; 2018 Dec; 9(1):5319. PubMed ID: 30552336
[TBL] [Abstract][Full Text] [Related]
18. Disruption of a long distance regulatory region upstream of SOX9 in isolated disorders of sex development.
Benko S; Gordon CT; Mallet D; Sreenivasan R; Thauvin-Robinet C; Brendehaug A; Thomas S; Bruland O; David M; Nicolino M; Labalme A; Sanlaville D; Callier P; Malan V; Huet F; Molven A; Dijoud F; Munnich A; Faivre L; Amiel J; Harley V; Houge G; Morel Y; Lyonnet S
J Med Genet; 2011 Dec; 48(12):825-30. PubMed ID: 22051515
[TBL] [Abstract][Full Text] [Related]
19. Wnt signaling in ovarian development inhibits Sf1 activation of Sox9 via the Tesco enhancer.
Bernard P; Ryan J; Sim H; Czech DP; Sinclair AH; Koopman P; Harley VR
Endocrinology; 2012 Feb; 153(2):901-12. PubMed ID: 22128028
[TBL] [Abstract][Full Text] [Related]
20. Sox9 gene regulation and the loss of the XY/XX sex-determining mechanism in the mole vole Ellobius lutescens.
Bagheri-Fam S; Sreenivasan R; Bernard P; Knower KC; Sekido R; Lovell-Badge R; Just W; Harley VR
Chromosome Res; 2012 Jan; 20(1):191-9. PubMed ID: 22215485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
